Alpine Immune Sciences (ALPN) Stock Forecast & Price Target

→ The “Perfect Storm” for Gold (From Gold Safe Exchange) (Ad)

$64.43

-0.03 (-0.05%)

(As of 04/18/2024 ET)

Alpine Immune Sciences Consensus Analyst Rating and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Analysts' Consensus Rating

Hold
Based on 11 Analyst Ratings

Analysts' Consensus Price Target

$50.33
-21.88% Downside

High Forecast	$65.00
Average Forecast	$50.33
Low Forecast	$18.00

Type	Current Forecast 4/19/23 to 4/18/24	1 Month Ago 3/20/23 to 3/19/24	3 Months Ago 1/19/23 to 1/19/24	1 Year Ago 4/19/22 to 4/19/23
Consensus Rating	Hold	Buy	Buy	Buy
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	3 Buy rating(s)	7 Buy rating(s)	6 Buy rating(s)	5 Buy rating(s)
Hold	8 Hold rating(s)	0 Hold rating(s)	0 Hold rating(s)	0 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$50.33	$38.86	$25.00	$16.40
Predicted Upside	-21.88% Downside	33.65% Upside	77.35% Upside	131.71% Upside

Get Alpine Immune Sciences Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for ALPN and its competitors with MarketBeat's FREE daily newsletter.

Ad Gold Safe Exchange

The “Perfect Storm” for Gold

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

Click here now to download the free Precious Metals Buying Guide!

ALPN Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

ALPN Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Alpine Immune Sciences Stock vs. The Competition

Type	Alpine Immune Sciences	Medical Companies	S&P 500
Consensus Rating Score	2.27	2.68	2.49
Consensus Rating	Hold	Moderate Buy	Hold
Predicted Upside	-21.92% Downside	933.43% Upside	11.75% Upside
News Sentiment Rating	Positive News	Neutral News	Positive News

Recent Analyst Ratings and Stock Forecasts

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
4/16/2024	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Buy ➝ Hold
4/12/2024	SVB Leerink Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Outperform ➝ Market Perform	$42.00 ➝ $65.00	+0.87%
4/11/2024	Leerink Partnrs Subscribe to MarketBeat All Access for the recommendation accuracy rating	T. Smith Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Outperform ➝ Market Perform
4/11/2024	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	J. Pantginis Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Buy ➝ Neutral
4/11/2024	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating	R. Driscoll Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Outperform ➝ Neutral
4/11/2024	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Overweight ➝ Equal Weight	$47.00 ➝ $65.00	+38.18%
Get the Latest News and Ratings for ALPN and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Alpine Immune Sciences and its competitors with MarketBeat's FREE daily newsletter.
4/11/2024	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Outperform ➝ Sector Perform	$41.00 ➝ $65.00	+38.18%
4/11/2024	Wolfe Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Outperform ➝ Peer Perform
4/9/2024	Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Buy	$55.00	+42.75%
3/19/2024	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Outperform ➝ Outperform	$33.00 ➝ $44.00	+24.05%
10/17/2023	Berenberg Bank Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Buy	$18.00	+80.00%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Thursday at 07:19 PM ET.

ALPN Price Target - Frequently Asked Questions

What is Alpine Immune Sciences's consensus rating and price target?: According to the issued ratings of 11 analysts in the last year, the consensus rating for Alpine Immune Sciences stock is Hold based on the current 8 hold ratings and 3 buy ratings for ALPN. The average twelve-month price prediction for Alpine Immune Sciences is $50.33 with a high price target of $65.00 and a low price target of $18.00. Learn more on ALPN's analyst rating history.
Do Wall Street analysts like Alpine Immune Sciences more than its competitors?: Analysts like Alpine Immune Sciences less than other Medical companies. The consensus rating for Alpine Immune Sciences is Hold while the average consensus rating for medical companies is Moderate Buy. Learn more on how ALPN compares to other companies.
Is Alpine Immune Sciences being downgraded by Wall Street analysts?: Over the previous 90 days, Alpine Immune Sciences's stock had 4 downgrades by analysts.

Does Alpine Immune Sciences's stock price have much upside?: According to analysts, Alpine Immune Sciences's stock has a predicted upside of 28.70% based on their 12-month stock forecasts.
What analysts cover Alpine Immune Sciences?: Alpine Immune Sciences has been rated by Guggenheim, HC Wainwright, Leerink Partnrs, Morgan Stanley, Oppenheimer, Royal Bank of Canada, SVB Leerink, TD Cowen, Wedbush, and Wolfe Research in the past 90 days.

Stock Ratings Reports and Tools

Related Companies:

Today's Ratings:

Top Rated Stocks:

More Ratings Tools:

This page (NASDAQ:ALPN) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Alpine Immune Sciences (ALPN) Stock Forecast & Price Target

Alpine Immune Sciences Consensus Analyst Rating and Stock Price Forecast (2024)

Analysts' Consensus Rating

Analysts' Consensus Price Target

ALPN Analyst Ratings By Month

ALPN Price Targets by Month

Alpine Immune Sciences Stock vs. The Competition

Recent Analyst Ratings and Stock Forecasts

ALPN Price Target - Frequently Asked Questions

Stock Ratings Reports and Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info